Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Quarterly Statistics: A Record-Breaking Q2 As Financings Surge

Executive Summary

Biopharma start-ups had a record-breading quarter in terms of fundraising. A review of biopharma start-up deal-making and financing activity from April through June 2018, based on data from Strategic Transactions.

Advertisement

Related Content

IPO Update: Returns Ride Rollercoaster Into Mid-Year As More Biopharmas Take The Plunge
Brii Bio: Partnering To Bring Innovation To China
Oxford BioMedica CEO To Hire More People, Expects More Deals Following Gene Therapy Pact With Axovant
Lilly Reacquires Aurora Kinase Inhibitor Via AurKa Buy For $110m
Start-Up Quarterly Statistics: Financings Finally Rise In Q1, But Deals Stagnate
Orchard To Use Divested GSK Rare Disease Gene Therapies To Grow Globally
Encapsulated Living Cells For Diabetes: The Final Push?
'We Jumped' At Opportunity To Take On Pfizer's CAR-T Program, Allogene's Chang Says
Deal Watch: Allogene Gets Pfizer's Off-The-Shelf CAR-T Program, $300m Series A Backing
Novartis Bolsters I-O Discovery Pipeline With Surface Oncology Deal

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC123510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel